Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 16, 2014

View Archived Issues

Alzheimer's disease organizations fund drug repurposing studies

Scientists at M2i Development disclose novel diagnostic agents

Array BioPharma grants Oncothyreon exclusive license to ONT-380

Galapagos selects GLPG-2222 as part of its triple combination therapy for cystic fibrosis

Alnylam initiates phase III trial of revusiran in transthyretin-mediated amyloidotic cardiomyopathy

Novel JAK2 inhibitor NVP-CHZ868 displays potent activity in vitro and in murine MPN models

Hutchison MediPharma initiates phase III trial of fruquintinib in colorectal cancer

Inhibition of EZH2 leads to tumor growth inhibition in B-cell lymphoma cell lines

Study describes levels of biomarker of brain insulin resistance in hippocampal regions

Animal model of osteochondromagenesis highlights role of NFATc1

Kolltan Pharmaceuticals describes anti-SCFR monoclonal antibody

Antitumor activity seen with HER2-T-cell-dependent bispecific antibody developed at Genentech

BioCryst begins phase I trial of BCX-4430 for hemorrhagic fever viruses

Synageva BioPharma confirms active IND application for SBC-103

Novel CXCR-7 modulators disclosed by Actelion Pharmaceuticals

Cephalon divulges novel ALK inhibitors for cancer

Taiho Pharmaceutical patents novel compounds for urinary incontinence

Teijin Pharma reports new XO inhibitors

New company BliNK Biomedical created to focus on antibody discovery

Anthera Pharmaceuticals licenses Japanese rights to blisibimod to Zenyaku Kogyo

New study evaluates dabigatran etexilate to prevent recurrent embolic stroke of undetermined source

NEOD-001 given FDA fast track designation for AL amyloidosis

IND accepted for ADXS-HPV plus MEDI-4736 in HPV-associated cancers

Neovacs' phase IIb trial of TNF-Kinoid in rheumatoid arthritis misses endpoint

FDA approves Signifor LAR for acromegaly

ViiV Healthcare applies for Japanese approval of dolutegravir/abacavir/lamivudine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...